Anti-hypertensive drugs and breast cancer risk
The project
Calcium channel blockers (CCBs) are drugs that are used to treat high blood pressure, also known as hypertension. Hypertension is one of the biggest risk factors for cardiovascular disease. Whilst these drugs are good at reducing hypertension, some research suggests they might increase the risk of breast cancer. Other studies have had mixed results in figuring out if CCBs are linked to breast cancer. One of the reasons for this is because there has been limited research that has followed people taking CCBs over a long period of time. Another reason is because different countries have different patterns in the drugs they prescribe people for hypertension. In Australia, CCBs are the second most commonly prescribed drug to treat hypertension.
The research team is using data from two long-term Australian survey studies, as well as a long-term Netherlands study, to find out if CCBs were linked to an increased risk of breast cancer. They will also be looking into whether the amount and length of use of CCBs make a difference.
The involvement opportunity
The research team are looking for two to four consumers to help them with two main tasks:
- Help them develop a survey to explore how people make treatment decisions, and how people balance the risks of breast cancer and cardiovascular disease.
- Help them determine how to communicate these findings to the public.
Skills and experience
You need to be a female who is currently taking medication to treat hypertension. You can be located anywhere in Australia.
Other information
The duration of involvement is one year. This will include approximately four meetings throughout the year.
Meetings will be held online.
An honorarium of $37.50/hour is provided for all activities including document review and meeting attendance. Training and support are offered by Curtin Involve.
Closing date: 17 August 2025